Data / Form D filings / Corner Therapeutics, Inc.
Corner Therapeutics, Inc.: Form D filings
Corner Therapeutics, Inc., a pharmaceuticals company in Watertown, MA, filed 4 Form D notices with the SEC between 2024 and 2025. The latest, on October 20, 2025, reports $16.8 million sold of a $16.8 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300 N. BEACON STREET, BUILDING 39, SUITE 202, Watertown, MA, 02472
- Phone
- (617) 701-7014
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2019875
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | New notice | $16,754,446 | $16,754,446 | 4 | Sep 26, 2025 | sec.gov | |
| Aug 11, 2025 | Amendment | $63,455,390 | $58,510,656 | $4,944,734 | 14 | May 31, 2023 | sec.gov |
| Apr 30, 2025 | Amendment | $53,681,969 | $53,441,210 | $240,759 | 14 | May 31, 2023 | sec.gov |
| Apr 23, 2024 | New notice | $50,941,210 | $50,941,210 | 14 | May 31, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alan Ezekowitz | Director | |
| Nick Seaver | Executive Officer, Director | |
| Jonathan Kagan | Executive Officer, Director | |
| Steven Altschuler | Executive Officer, Director | |
| Richard Malley | Director | |
| Andrew Bellinger | Director | |
| Andrew Cornforth | Executive Officer | |
| Garrett Nichols | Executive Officer |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Corner Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.